Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Antivirals Market Research Report 2025

Global Antivirals Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-02-25

Pages: 90 Pages

Report ld: 4302646

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Antivirals Market Size(US$)

CAGR 2025-2031

4.5%

Market Size,2031

USD 67,770

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 52,040 million

Market Forecast in 2031(Value)

US$ 67,770 million

CAGR

4.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Antivirals was valued at US$ 50010 million in the year 2024 and is projected to reach a revised size of US$ 67770 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Antivirals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivirals.

The Antivirals market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antivirals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antivirals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Merck

Johnson & Johnson

Teva Pharmaceutical Industries

GSK

Mylan

Gilead Sciences

F. Hoffmann-La Roche

Bristol-Myers-Squibb

AbbVie

Aurobindo Pharma

Cipla

Dr Reddy’s

Segment by Type

Generic

Branded

Segment by Application

HIV

Hepatitis

HSV

Influenza

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Antivirals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Antivirals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Antivirals Market Overview

1.1 Product Definition

1.2 Antivirals by Type

1.2.1 Global Antivirals Market Value Comparison by Type (2024 VS 2031)

1.2.2 Generic

1.2.3 Branded

1.3 Antivirals by Application

1.3.1 Global Antivirals Market Value by Application (2024 VS 2031)

1.3.2 HIV

1.3.3 Hepatitis

1.3.4 HSV

1.3.5 Influenza

1.4 Global Antivirals Market Size Estimates and Forecasts

1.4.1 Global Antivirals Revenue 2020-2031

1.4.2 Global Antivirals Sales 2020-2031

1.4.3 Global Antivirals Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antivirals Market Competition by Manufacturers

2.1 Global Antivirals Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antivirals Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antivirals Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antivirals, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antivirals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antivirals, Product Type & Application

2.7 Global Key Manufacturers of Antivirals, Date of Enter into This Industry

2.8 Global Antivirals Market Competitive Situation and Trends

2.8.1 Global Antivirals Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antivirals Players Market Share by Revenue

2.8.3 Global Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antivirals Market Scenario by Region

3.1 Global Antivirals Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antivirals Sales by Region: 2020-2031

3.2.1 Global Antivirals Sales by Region: 2020-2025

3.2.2 Global Antivirals Sales by Region: 2026-2031

3.3 Global Antivirals Revenue by Region: 2020-2031

3.3.1 Global Antivirals Revenue by Region: 2020-2025

3.3.2 Global Antivirals Revenue by Region: 2026-2031

3.4 North America Antivirals Market Facts & Figures by Country

3.4.1 North America Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antivirals Sales by Country (2020-2031)

3.4.3 North America Antivirals Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Antivirals Market Facts & Figures by Country

3.5.1 Europe Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antivirals Sales by Country (2020-2031)

3.5.3 Europe Antivirals Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antivirals Market Facts & Figures by Region

3.6.1 Asia Pacific Antivirals Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antivirals Sales by Region (2020-2031)

3.6.3 Asia Pacific Antivirals Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Antivirals Market Facts & Figures by Country

3.7.1 Latin America Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antivirals Sales by Country (2020-2031)

3.7.3 Latin America Antivirals Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antivirals Market Facts & Figures by Country

3.8.1 Middle East and Africa Antivirals Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antivirals Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antivirals Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Antivirals Sales by Type (2020-2031)

4.1.1 Global Antivirals Sales by Type (2020-2025)

4.1.2 Global Antivirals Sales by Type (2026-2031)

4.1.3 Global Antivirals Sales Market Share by Type (2020-2031)

4.2 Global Antivirals Revenue by Type (2020-2031)

4.2.1 Global Antivirals Revenue by Type (2020-2025)

4.2.2 Global Antivirals Revenue by Type (2026-2031)

4.2.3 Global Antivirals Revenue Market Share by Type (2020-2031)

4.3 Global Antivirals Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antivirals Sales by Application (2020-2031)

5.1.1 Global Antivirals Sales by Application (2020-2025)

5.1.2 Global Antivirals Sales by Application (2026-2031)

5.1.3 Global Antivirals Sales Market Share by Application (2020-2031)

5.2 Global Antivirals Revenue by Application (2020-2031)

5.2.1 Global Antivirals Revenue by Application (2020-2025)

5.2.2 Global Antivirals Revenue by Application (2026-2031)

5.2.3 Global Antivirals Revenue Market Share by Application (2020-2031)

5.3 Global Antivirals Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Antivirals Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Company Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Johnson & Johnson Antivirals Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Teva Pharmaceutical Industries

6.3.1 Teva Pharmaceutical Industries Company Information

6.3.2 Teva Pharmaceutical Industries Description and Business Overview

6.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Pharmaceutical Industries Antivirals Product Portfolio

6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.4 GSK

6.4.1 GSK Company Information

6.4.2 GSK Description and Business Overview

6.4.3 GSK Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GSK Antivirals Product Portfolio

6.4.5 GSK Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Company Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Antivirals Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Gilead Sciences

6.6.1 Gilead Sciences Company Information

6.6.2 Gilead Sciences Description and Business Overview

6.6.3 Gilead Sciences Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Gilead Sciences Antivirals Product Portfolio

6.6.5 Gilead Sciences Recent Developments/Updates

6.7 F. Hoffmann-La Roche

6.7.1 F. Hoffmann-La Roche Company Information

6.7.2 F. Hoffmann-La Roche Description and Business Overview

6.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.7.4 F. Hoffmann-La Roche Antivirals Product Portfolio

6.7.5 F. Hoffmann-La Roche Recent Developments/Updates

6.8 Bristol-Myers-Squibb

6.8.1 Bristol-Myers-Squibb Company Information

6.8.2 Bristol-Myers-Squibb Description and Business Overview

6.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Bristol-Myers-Squibb Antivirals Product Portfolio

6.8.5 Bristol-Myers-Squibb Recent Developments/Updates

6.9 AbbVie

6.9.1 AbbVie Company Information

6.9.2 AbbVie Description and Business Overview

6.9.3 AbbVie Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.9.4 AbbVie Antivirals Product Portfolio

6.9.5 AbbVie Recent Developments/Updates

6.10 Aurobindo Pharma

6.10.1 Aurobindo Pharma Company Information

6.10.2 Aurobindo Pharma Description and Business Overview

6.10.3 Aurobindo Pharma Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Aurobindo Pharma Antivirals Product Portfolio

6.10.5 Aurobindo Pharma Recent Developments/Updates

6.11 Cipla

6.11.1 Cipla Company Information

6.11.2 Cipla Description and Business Overview

6.11.3 Cipla Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Cipla Antivirals Product Portfolio

6.11.5 Cipla Recent Developments/Updates

6.12 Dr Reddy’s

6.12.1 Dr Reddy’s Company Information

6.12.2 Dr Reddy’s Description and Business Overview

6.12.3 Dr Reddy’s Antivirals Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Dr Reddy’s Antivirals Product Portfolio

6.12.5 Dr Reddy’s Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antivirals Industry Chain Analysis

7.2 Antivirals Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antivirals Production Mode & Process Analysis

7.4 Antivirals Sales and Marketing

7.4.1 Antivirals Sales Channels

7.4.2 Antivirals Distributors

7.5 Antivirals Customer Analysis

8 Antivirals Market Dynamics

8.1 Antivirals Industry Trends

8.2 Antivirals Market Drivers

8.3 Antivirals Market Challenges

8.4 Antivirals Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Antivirals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antivirals Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antivirals Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antivirals Sales (K MT) of Key Manufacturers (2020-2025)

Table 5. Global Antivirals Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antivirals Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antivirals Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antivirals Average Price (USD/MT) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antivirals, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antivirals, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antivirals, Product Type & Application

Table 12. Global Key Manufacturers of Antivirals, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antivirals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antivirals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antivirals Sales by Region (2020-2025) & (K MT)

Table 18. Global Antivirals Sales Market Share by Region (2020-2025)

Table 19. Global Antivirals Sales by Region (2026-2031) & (K MT)

Table 20. Global Antivirals Sales Market Share by Region (2026-2031)

Table 21. Global Antivirals Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antivirals Revenue Market Share by Region (2020-2025)

Table 23. Global Antivirals Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antivirals Revenue Market Share by Region (2026-2031)

Table 25. North America Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antivirals Sales by Country (2020-2025) & (K MT)

Table 27. North America Antivirals Sales by Country (2026-2031) & (K MT)

Table 28. North America Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antivirals Sales by Country (2020-2025) & (K MT)

Table 32. Europe Antivirals Sales by Country (2026-2031) & (K MT)

Table 33. Europe Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antivirals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antivirals Sales by Region (2020-2025) & (K MT)

Table 37. Asia Pacific Antivirals Sales by Region (2026-2031) & (K MT)

Table 38. Asia Pacific Antivirals Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antivirals Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antivirals Sales by Country (2020-2025) & (K MT)

Table 42. Latin America Antivirals Sales by Country (2026-2031) & (K MT)

Table 43. Latin America Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antivirals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antivirals Sales by Country (2020-2025) & (K MT)

Table 47. Middle East and Africa Antivirals Sales by Country (2026-2031) & (K MT)

Table 48. Middle East and Africa Antivirals Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antivirals Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antivirals Sales (K MT) by Type (2020-2025)

Table 51. Global Antivirals Sales (K MT) by Type (2026-2031)

Table 52. Global Antivirals Sales Market Share by Type (2020-2025)

Table 53. Global Antivirals Sales Market Share by Type (2026-2031)

Table 54. Global Antivirals Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antivirals Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antivirals Revenue Market Share by Type (2020-2025)

Table 57. Global Antivirals Revenue Market Share by Type (2026-2031)

Table 58. Global Antivirals Price (USD/MT) by Type (2020-2025)

Table 59. Global Antivirals Price (USD/MT) by Type (2026-2031)

Table 60. Global Antivirals Sales (K MT) by Application (2020-2025)

Table 61. Global Antivirals Sales (K MT) by Application (2026-2031)

Table 62. Global Antivirals Sales Market Share by Application (2020-2025)

Table 63. Global Antivirals Sales Market Share by Application (2026-2031)

Table 64. Global Antivirals Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antivirals Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antivirals Revenue Market Share by Application (2020-2025)

Table 67. Global Antivirals Revenue Market Share by Application (2026-2031)

Table 68. Global Antivirals Price (USD/MT) by Application (2020-2025)

Table 69. Global Antivirals Price (USD/MT) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Merck Antivirals Product

Table 74. Merck Recent Developments/Updates

Table 75. Johnson & Johnson Company Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Johnson & Johnson Antivirals Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Teva Pharmaceutical Industries Company Information

Table 81. Teva Pharmaceutical Industries Description and Business Overview

Table 82. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. Teva Pharmaceutical Industries Antivirals Product

Table 84. Teva Pharmaceutical Industries Recent Developments/Updates

Table 85. GSK Company Information

Table 86. GSK Description and Business Overview

Table 87. GSK Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. GSK Antivirals Product

Table 89. GSK Recent Developments/Updates

Table 90. Mylan Company Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Mylan Antivirals Product

Table 94. Mylan Recent Developments/Updates

Table 95. Gilead Sciences Company Information

Table 96. Gilead Sciences Description and Business Overview

Table 97. Gilead Sciences Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Gilead Sciences Antivirals Product

Table 99. Gilead Sciences Recent Developments/Updates

Table 100. F. Hoffmann-La Roche Company Information

Table 101. F. Hoffmann-La Roche Description and Business Overview

Table 102. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. F. Hoffmann-La Roche Antivirals Product

Table 104. F. Hoffmann-La Roche Recent Developments/Updates

Table 105. Bristol-Myers-Squibb Company Information

Table 106. Bristol-Myers-Squibb Description and Business Overview

Table 107. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. Bristol-Myers-Squibb Antivirals Product

Table 109. Bristol-Myers-Squibb Recent Developments/Updates

Table 110. AbbVie Company Information

Table 111. AbbVie Description and Business Overview

Table 112. AbbVie Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. AbbVie Antivirals Product

Table 114. AbbVie Recent Developments/Updates

Table 115. Aurobindo Pharma Company Information

Table 116. Aurobindo Pharma Description and Business Overview

Table 117. Aurobindo Pharma Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. Aurobindo Pharma Antivirals Product

Table 119. Aurobindo Pharma Recent Developments/Updates

Table 120. Cipla Company Information

Table 121. Cipla Description and Business Overview

Table 122. Cipla Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 123. Cipla Antivirals Product

Table 124. Cipla Recent Developments/Updates

Table 125. Dr Reddy’s Company Information

Table 126. Dr Reddy’s Description and Business Overview

Table 127. Dr Reddy’s Antivirals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 128. Dr Reddy’s Antivirals Product

Table 129. Dr Reddy’s Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Antivirals Distributors List

Table 133. Antivirals Customers List

Table 134. Antivirals Market Trends

Table 135. Antivirals Market Drivers

Table 136. Antivirals Market Challenges

Table 137. Antivirals Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antivirals

Figure 2. Global Antivirals Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antivirals Market Share by Type: 2024 & 2031

Figure 4. Generic Product Picture

Figure 5. Branded Product Picture

Figure 6. Global Antivirals Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Antivirals Market Share by Application: 2024 & 2031

Figure 8. HIV

Figure 9. Hepatitis

Figure 10. HSV

Figure 11. Influenza

Figure 12. Global Antivirals Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antivirals Market Size (2020-2031) & (US$ Million)

Figure 14. Global Antivirals Sales (2020-2031) & (K MT)

Figure 15. Global Antivirals Average Price (USD/MT) & (2020-2031)

Figure 16. Antivirals Report Years Considered

Figure 17. Antivirals Sales Share by Manufacturers in 2024

Figure 18. Global Antivirals Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Antivirals Players: Market Share by Revenue in Antivirals in 2024

Figure 20. Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Antivirals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Antivirals Sales Market Share by Country (2020-2031)

Figure 23. North America Antivirals Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Antivirals Sales Market Share by Country (2020-2031)

Figure 27. Europe Antivirals Revenue Market Share by Country (2020-2031)

Figure 28. Germany Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Antivirals Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Antivirals Revenue Market Share by Region (2020-2031)

Figure 35. China Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Antivirals Sales Market Share by Country (2020-2031)

Figure 46. Latin America Antivirals Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Antivirals Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Antivirals Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Antivirals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Antivirals by Type (2020-2031)

Figure 56. Global Revenue Market Share of Antivirals by Type (2020-2031)

Figure 57. Global Antivirals Price (USD/MT) by Type (2020-2031)

Figure 58. Global Sales Market Share of Antivirals by Application (2020-2031)

Figure 59. Global Revenue Market Share of Antivirals by Application (2020-2031)

Figure 60. Global Antivirals Price (USD/MT) by Application (2020-2031)

Figure 61. Antivirals Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Antivirals market? zhanKai

The top companies in the global Antivirals market are Merck、Johnson & Johnson、Teva Pharmaceutical Industries.

Which region is expected to have the highest market share? shouQi

What was the global market size of Antivirals in 2025? shouQi

What is the annual compound growth rate of the global Antivirals market size from 2025 to 2031? shouQi

What was the global market size of Antivirals in 2031? shouQi

Related Reports

Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antivirals was estimated to be worth US$ 52040 million in 2025 and is projected to reach US$ 70510 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
Global Antivirals Market Research Report 2026
The global Antivirals market was valued at US$ 52040 million in 2025 and is anticipated to reach US$ 70510 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 121
USD 2900.00
(Single User License)
Global Antivirals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antivirals market size was US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 92
USD 4250.00
(Single User License)
Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antivirals was estimated to be worth US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 119
USD 3950.00
(Single User License)
Global Antivirals Market Insights, Forecast to 2030
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Antivirals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published Date: 2024-01-24
Pages: 124
USD 3950.00
(Single User License)
Global Antivirals Market Research Report 2024
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published Date: 2024-01-16
Pages: 90
USD 2900.00
(Single User License)

Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antivirals was estimated to be worth US$ 52040 million in 2025 and is projected to reach US$ 70510 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-07-14
Pages: 140
USD 3950.00 (Single User License)
Global Antivirals Market Research Report 2026
The global Antivirals market was valued at US$ 52040 million in 2025 and is anticipated to reach US$ 70510 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-04-27
Pages: 121
USD 2900.00 (Single User License)
Global Antivirals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antivirals market size was US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 92
USD 4250.00 (Single User License)
Antivirals- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antivirals was estimated to be worth US$ 50010 million in 2024 and is forecast to a readjusted size of US$ 67770 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 119
USD 3950.00 (Single User License)
Global Antivirals Market Insights, Forecast to 2030
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)
Antivirals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published: 2024-01-24
Pages: 124
USD 3950.00 (Single User License)
Global Antivirals Market Research Report 2024
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
Published: 2024-01-16
Pages: 90
USD 2900.00 (Single User License)